Other substances

ZINC104875569

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
2
 AI-suggested references
0
 Clinical trials

General information

ZINC104875569 on PubChem

Synonyms

2600; (2S,3S,4S)-2-(4-Hydroxyphenyl)-3,4-dihydro-2H-chromene-3,4,5,7-tetrol

 

Structure image - ZINC104875569

C1=CC(=CC=C1[C@H]2[C@H]([C@H](C3=C(C=C(C=C3O2)O)O)O)O)O

Supporting references

Link Tested on Impact factor Notes Publication date
Computational search for drug repurposing to identify potential inhibitors against SARS-COV-2 using Molecular Docking, QTAIM and IQA methods in viral Spike protein – Human ACE2 interface
Spike protein ACE2 Small molecule In silico 		in silico 2.46

Predicted to block the SARS-CoV-2 Spike protein-host ACE2 receptor interaction when combined with S-8510.

 Feb/08/2021

AI-suggested references

Link Publication date
Computational search for drug repurposing to identify potential inhibitors against SARS-COV-2 using Molecular Docking, QTAIM and IQA methods in viral Spike protein - Human ACE2 interface.
Feb/08/2021
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
Nov/22/2020
Export (.csv)